![]() |
|||
|
|
|
|
| UPDATE: February 2009 | MW: 419.91 | MF: C19H21N5O4•ClH |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
N/R
|
N/R
|
N/R
|
N/R
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
implant | rat
lowest published toxic dose: 30 mg/kg (3 day male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Effects on fertility: Male fertility index (e.g., # males impregnating females per # males exposed to fertile nonpregnant females)
JRPFA4 70,643,1984
|
oral | rat
lowest published toxic dose: 4,150 mg/kg (8 week male/2 week prior to copulation-9 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
OYYAA2 17,57,1979
|
oral | rat
lowest published toxic dose: 300 mg/kg (9-14 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetal death
|
OYYAA2 17,57,1979
|
oral | rat
lowest published toxic dose: 8,700 mg/kg (14-22 day pregnant/20 day after birth)
|
Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive)
|
OYYAA2 17,57,1979
|
oral | rat
lowest published toxic dose: 1,450 mg/kg (14-22 day pregnant/20 day after birth)
|
Reproductive: Effects on newborn: Weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
|
OYYAA2 17,57,1979
|
oral | rabbit
lowest published toxic dose: 90 mg/kg (9-14 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetal death
|
OYYAA2 17,57,1979
|
oral | rabbit
lowest published toxic dose: 450 mg/kg (9-14 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
OYYAA2 17,57,1979
|
subcutaneous | rat
lowest published toxic dose: 4 mg/kg (22 day pregnant)
|
Reproductive: Maternal effects: Parturition
|
JRPFA4 76,415,1986
|
subcutaneous | rat
lowest published toxic dose: 12 mg/kg (4-5 day pregnant)
|
Reproductive: Maternal effects: Uterus, cervix, vagina | Reproductive: Other effects on female
JRPFA4 81,51,1987
|
subcutaneous | rat
lowest published toxic dose: 1,400 mg/kg (1 day male)
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct | Reproductive: Effects on fertility: Male fertility index (e.g., # males impregnating females per # males exposed to fertile nonpregnant females) Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea)
CCPTAY 41,441,1990
|
unreported route | dog
lowest published toxic dose: 9,125 mg/kg (52 week male)
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
YHTPAD 18,343,1983
|
unreported route | rat
lowest published toxic dose: 9,125 mg/kg (52 week male)
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
YHTPAD 18,343,1983
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lethal dose (50 percent kill): 60 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Ataxia Gastrointestinal: Hypermotility, diarrhea
OYYAA2 17,39,1979
|
intraperitoneal | mouse
lowest published toxic dose: 1 mg/kg
|
Nutritional and Gross Metabolic: Body temperature decrease
|
PHTOEH 93,48,2003
|
intraperitoneal | mouse
lowest published toxic dose: 0.125 mg/kg
|
Behavioral: Analgesia
|
PHMCAA 68,154,2003
|
intraperitoneal | mouse
lowest published toxic dose: 0.25 mg/kg
|
Eye: Ptosis | Behavioral: Tremor Behavioral: Change in motor activity (specific assay)
AEPPAE 369,338,2004
|
intraperitoneal | rat
lethal dose (50 percent kill): 102 mg/kg
|
Eye: Lacrimation | Behavioral: Somnolence (general depressed activity) Lung, Thorax, or Respiration: Respiratory depression
OYYAA2 17,39,1979
|
intraperitoneal | rat
lowest published toxic dose: 0.3 mg/kg
|
Behavioral: Change in motor activity (specific assay)
|
PSCHDL 169,176,2003
|
intraperitoneal | rat
lowest published toxic dose: 8 mg/kg
|
Behavioral: Alteration of operant conditioning
|
PSCHDL 171,212,2004
|
intravenous | dog
lowest published toxic dose: 2,981 ng/kg
|
Vascular: BP lowering not characterized in autonomic section
|
EJPHAZ 497,327,2004
|
intravenous | dog
lowest published toxic dose: 4,031 ng/kg
|
Autonomic Nervous System: Central sympatholytic | Kidney, Ureter, and Bladder: Other changes
EJPHAZ 497,327,2004
|
intravenous | dog
lowest published toxic dose: 5.3 µg/kg
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
EJPHAZ 580,256,2008
|
intravenous | dog
lowest published toxic dose: 13 µg/kg
|
Kidney, Ureter, and Bladder: Structural or functional change in ureter | Reproductive: Paternal effects: Testes, epididymis, sperm duct
EJPHAZ 580,256,2008
|
intravenous | guinea pig
lowest published toxic dose: 0.1 mg/kg
|
Vascular: BP lowering not characterized in autonomic section
|
EJPHAZ 452,97,2002
|
intravenous | mouse
lethal dose (50 percent kill): 92 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Behavioral: Ataxia Lung, Thorax, or Respiration: Dyspnea
NCDREP 4,1,1986
|
intravenous | rat
lethal dose (50 percent kill): 73 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Behavioral: Ataxia Lung, Thorax, or Respiration: Dyspnea
NCDREP 4,1,1986
|
intravenous | rat
lowest published toxic dose: 0.3 mg/kg
|
Peripheral Nerve and Sensation: Recording from afferent nerve
|
EJPHAZ 489,207,2004
|
intravenous | rat
lowest published toxic dose: 1 µg/kg
|
Vascular: BP lowering not characterized in autonomic section
|
BJPCBM 145,567,2005
|
intravenous | rabbit
lowest published toxic dose: 3,000 µg/kg
|
Eye: Miosis (pupilliary constriction)
|
AEPPAE 372,346,2006
|
oral | dog
lethal dose (50 percent kill): >700 mg/kg
|
Gastrointestinal: Changes in structure or function of salivary glands | Gastrointestinal: Nausea or vomiting Kidney, Ureter, and Bladder: Other changes
OYYAA2 17,39,1979
|
oral | human
lowest published toxic dose: 285 µg/kg
|
Vascular: BP lowering not characterized in autonomic section
|
JAMAAP 238,157,1977
|
oral | man
lowest published toxic dose: 1,714 µg/kg
|
Behavioral: Coma | Lung, Thorax, or Respiration: Dyspnea
HUTODJ 4,53,1985
|
oral | mouse
lethal dose (50 percent kill): 5 gm/kg
|
N/R
|
MDACAP 11,64,1975
|
oral | rat
lethal dose (50 percent kill): 1,950 mg/kg
|
Gastrointestinal: Changes in structure or function of salivary glands | Gastrointestinal: Nausea or vomiting Kidney, Ureter, and Bladder: Other changes
OYYAA2 17,39,1979
|
oral | woman
lowest published toxic dose: 13 mg/kg/6 week- intermittent
|
Brain and Coverings: Encephalitis | Behavioral: Somnolence (general depressed activity) Behavioral: Toxic psychosis
BMJOAE 293,1347,1986
|
oral | woman
lowest published toxic dose: 10 µg/kg
|
Behavioral: Coma | Vascular: BP lowering not characterized in autonomic section Skin and Appendages: Other: Sweating
DICPBB 21,723,1987
|
subcutaneous | mouse
lethal dose (50 percent kill): 3,100 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Ataxia Lung, Thorax, or Respiration: Respiratory depression
OYYAA2 17,39,1979
|
subcutaneous | rat
lethal dose (50 percent kill): 3,750 mg/kg
|
Eye: Lacrimation | Behavioral: Somnolence (general depressed activity) Lung, Thorax, or Respiration: Respiratory depression
OYYAA2 17,39,1979
|
subcutaneous | rat
lowest published toxic dose: 0.5 mg/kg
|
Behavioral: Alteration of classical conditioning | Behavioral: Change in psychophysiological tests
PSCHDL 177,438,2005
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | rat
lowest published toxic dose: 2.6 mg/kg/7 day- intermittent
|
Brain and Coverings: Other degenerative changes
|
PHREP* 57,850,2005
|
oral | rat
lowest published toxic dose: 19,840 mg/kg/31 day- intermittent
|
Cardiac: Changes in heart weight | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Related to Chronic Data: Changes in ovarian weight
OYYAA2 17,39,1979
|
oral | rat
lowest published toxic dose: 582 gm/kg/5 week- intermittent
|
Kidney, Ureter, and Bladder: Other changes | Endocrine: Changes in spleen weight Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)
OYYAA2 17,39,1979
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X4879 |
Number of Industries 1; Total Number of Facilities 70; Number of Occupations 1; Total Number of Employees Exposed 1,092; Total Number of Female Employees Exposed 700 | |||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
N/R
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
AEPPAE
|
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.)
V.110-253, 1925-66. For publisher information, see NSAPCC.
|
BJPCBM
|
British Journal of Pharmacology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21
2XS, UK) V.34- 1968-
|
BMJOAE
|
British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR,
UK) V.1- 1857-
|
CCPTAY
|
Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1- 1970-
|
DICPBB
|
Drug Intelligence and Clinical Pharmacy. (POB 42435, Cincinnati, OH 45242) V.3- 1969-
|
EJPHAZ
|
European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam,
Netherlands) V.1- 1967-
|
HUTODJ
|
Human Toxicology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants., RG 21 2XS, UK) V.1-
1981-
|
JAMAAP
|
JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL
60610) V.1- 1883-
|
JRPFA4
|
Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way,
Colchester, Essex CO2 8HP, UK) V.1- 1960-
|
MDACAP
|
Medicamentos de Actualidad. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona,
Spain) V.1- 1965-
|
NCDREP
|
New Cardiovascular Drugs. (Raven Press, 1185 Ave. of the Americas, New York, NY 10036) 1985-
|
OYYAA2
|
Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1-
1967-
|
PHMCAA
|
Pharmacologist. (American Soc. for Pharmacology and Experimental Therapeutics, 9650 Rockville
Pike, Bethesda, MD 20014) V.1- 1959-
|
PHREP*
|
|
PHTOEH
|
Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016
Copenhagen K, Denmark) V.60- 1987-
|
PSCHDL
|
Psychopharmacology (Berlin). (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way,
Secaucus, NJ 07094) V.47- 1976-
|
YHTPAD
|
Yaoxue Tongbao. Bulletin of Pharmacology. (China International Book Trading Corp., POB 2820,
Beijing, Peop. Rep. China) V.13-23, 1978-88. For publisher information, see ZYZAEU.
|
| |